ANI Pharmaceuticals Inc (ANIP)
55.86
+0.76
(+1.38%)
USD |
NASDAQ |
Nov 21, 16:00
55.80
-0.06
(-0.11%)
Pre-Market: 09:02
ANI Pharmaceuticals Total Liabilities (Quarterly): 856.58M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 856.58M |
| June 30, 2024 | 440.14M |
| March 31, 2024 | 437.71M |
| December 31, 2023 | 446.82M |
| September 30, 2023 | 435.20M |
| June 30, 2023 | 424.87M |
| March 31, 2023 | 425.74M |
| December 31, 2022 | 421.55M |
| September 30, 2022 | 402.44M |
| June 30, 2022 | 414.38M |
| March 31, 2022 | 398.75M |
| December 31, 2021 | 412.86M |
| September 30, 2021 | 279.05M |
| June 30, 2021 | 288.24M |
| March 31, 2021 | 260.13M |
| December 31, 2020 | 265.49M |
| September 30, 2020 | 267.48M |
| June 30, 2020 | 274.05M |
| March 31, 2020 | 281.06M |
| December 31, 2019 | 244.00M |
| September 30, 2019 | 243.64M |
| June 30, 2019 | 239.25M |
| March 31, 2019 | 234.68M |
| December 31, 2018 | 233.34M |
| September 30, 2018 | 246.98M |
| Date | Value |
|---|---|
| June 30, 2018 | 239.07M |
| March 31, 2018 | 238.38M |
| December 31, 2017 | 237.38M |
| September 30, 2017 | 187.67M |
| June 30, 2017 | 182.67M |
| March 31, 2017 | 184.93M |
| December 31, 2016 | 153.22M |
| September 30, 2016 | 150.55M |
| June 30, 2016 | 144.22M |
| March 31, 2016 | 131.41M |
| December 31, 2015 | 125.18M |
| September 30, 2015 | 127.38M |
| June 30, 2015 | 120.62M |
| March 31, 2015 | 121.24M |
| December 31, 2014 | 119.77M |
| September 30, 2014 | 8.145M |
| June 30, 2014 | 3.828M |
| March 31, 2014 | 4.56M |
| December 31, 2013 | 3.538M |
| September 30, 2013 | 6.597M |
| June 30, 2013 | 6.163M |
| March 31, 2013 | 9.326M |
| December 31, 2012 | 10.59M |
| September 30, 2012 | 10.92M |
| June 30, 2012 | 16.37M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
244.00M
Minimum
Dec 2019
856.58M
Maximum
Sep 2024
383.83M
Average
407.65M
Median
Total Liabilities (Quarterly) Benchmarks
| Windtree Therapeutics Inc | 25.21M |
| Allogene Therapeutics Inc | 125.37M |
| AIM ImmunoTech Inc | 10.68M |
| Protalix BioTherapeutics Inc | 29.13M |
| Armata Pharmaceuticals Inc | 149.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.287B |
| Shareholders Equity (Quarterly) | 430.80M |
| Debt to Equity Ratio | 1.452 |
| Current Ratio | 2.745 |
| Net Debt Paydown Yield | -5.40% |